Literature DB >> 22045807

Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1.

Jonathan Brown1, Huizhi Wang, Jill Suttles, Dana T Graves, Michael Martin.   

Abstract

Activation of the PI3K pathway plays a pivotal role in regulating the inflammatory response. The loss of mTORC2 has been shown to abrogate the activation of Akt, a critical downstream component of PI3K signaling. However, the biological importance of mTORC2 in innate immunity is currently unknown. Here we demonstrate that rictor, a key component of mTORC2, plays a critical role in controlling the innate inflammatory response via its ability to regulate FoxO1. Upon LPS stimulation, both rictor-deficient mouse embryonic fibroblasts (MEFs) and rictor knockdown dendritic cells exhibited a hyperinflammatory phenotype. The hyperinflammatory phenotype was due to a defective Akt signaling axis, because both rictor-deficient MEFs and rictor knockdown dendritic cells exhibited attenuated Akt phosphorylation and kinase activity. Analysis of downstream Akt targets revealed that phosphorylation of FoxO1 was impaired in rictor-deficient cells, resulting in elevated nuclear FoxO1 levels and diminished nuclear export of FoxO1 upon LPS stimulation. Knockdown of FoxO1 attenuated the hyperinflammatory phenotype exhibited by rictor-deficient MEFs. Moreover, FoxO1 deletion in dendritic cells attenuated the capacity of LPS to induce inflammatory cytokine expression. These findings identify a novel signaling pathway by which mTORC2 regulates the TLR-mediated inflammatory response through its ability to regulate FoxO1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22045807      PMCID: PMC3247956          DOI: 10.1074/jbc.M111.258053

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  The phosphoinositide 3-kinase pathway.

Authors:  Lewis C Cantley
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

2.  FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages.

Authors:  Wuqiang Fan; Hidetaka Morinaga; Jane J Kim; Eunju Bae; Nathanael J Spann; Sven Heinz; Christopher K Glass; Jerrold M Olefsky
Journal:  EMBO J       Date:  2010-11-02       Impact factor: 11.598

3.  Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways.

Authors:  Keunwook Lee; Prathyusha Gudapati; Srdjan Dragovic; Charles Spencer; Sebastian Joyce; Nigel Killeen; Mark A Magnuson; Mark Boothby
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

4.  Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343.

Authors:  S Persad; S Attwell; V Gray; N Mawji; J T Deng; D Leung; J Yan; J Sanghera; M P Walsh; S Dedhar
Journal:  J Biol Chem       Date:  2001-04-19       Impact factor: 5.157

5.  Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.

Authors:  G Rena; A R Prescott; S Guo; P Cohen; T G Unterman
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

6.  Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway.

Authors:  L Arbibe; J P Mira; N Teusch; L Kline; M Guha; N Mackman; P J Godowski; R J Ulevitch; U G Knaus
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

7.  Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice.

Authors:  Taro Fukao; Taketo Yamada; Masanobu Tanabe; Yasuo Terauchi; Takayuki Ota; Tetsuro Takayama; Tomoichiro Asano; Tsutomu Takeuchi; Takashi Kadowaki; Jun-ichi Hata Ji; Shigeo Koyasu
Journal:  Nat Immunol       Date:  2002-02-19       Impact factor: 25.606

8.  Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1).

Authors:  M F Siqueira; J Li; L Chehab; T Desta; T Chino; N Krothpali; Y Behl; M Alikhani; J Yang; C Braasch; D T Graves
Journal:  Diabetologia       Date:  2009-11-10       Impact factor: 10.122

9.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

10.  FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages.

Authors:  Dongming Su; Gina M Coudriet; Dae Hyun Kim; Yi Lu; German Perdomo; Shen Qu; Sandra Slusher; Hubert M Tse; Jon Piganelli; Nick Giannoukakis; Jian Zhang; H Henry Dong
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

View more
  79 in total

Review 1.  Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.

Authors:  Jessica A Hamerman; Jessica Pottle; Minjian Ni; Yantao He; Zhong-Yin Zhang; Jane H Buckner
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

2.  Adaptive inflammatory microenvironment for cell-based regeneration in ischemic cardiovascular disease.

Authors:  Weiwei Fan; Jibin Zhang; Zheng Zhang; Qiong Wang; Feng Cao
Journal:  Organogenesis       Date:  2013-07-03       Impact factor: 2.500

3.  Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis.

Authors:  Karl Katholnig; Birgit Schütz; Stephanie D Fritsch; David Schörghofer; Monika Linke; Nyamdelger Sukhbaatar; Julia M Matschinger; Daniela Unterleuthner; Martin Hirtl; Michaela Lang; Merima Herac; Andreas Spittler; Andreas Bergthaler; Gernot Schabbauer; Michael Bergmann; Helmut Dolznig; Markus Hengstschläger; Mark A Magnuson; Mario Mikula; Thomas Weichhart
Journal:  JCI Insight       Date:  2019-10-17

4.  Rapamycin induces mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) expression through activation of protein kinase B and mitogen-activated protein kinase kinase pathways.

Authors:  Ruchi Rastogi; Zhongliang Jiang; Nisar Ahmad; Rita Rosati; Yusen Liu; Laurent Beuret; Robert Monks; Jean Charron; Morris J Birnbaum; Lobelia Samavati
Journal:  J Biol Chem       Date:  2013-10-14       Impact factor: 5.157

5.  mTORC2 Deficiency in Myeloid Dendritic Cells Enhances Their Allogeneic Th1 and Th17 Stimulatory Ability after TLR4 Ligation In Vitro and In Vivo.

Authors:  Dàlia Raïch-Regué; Brian R Rosborough; Alicia R Watson; Mandy J McGeachy; Hēth R Turnquist; Angus W Thomson
Journal:  J Immunol       Date:  2015-04-03       Impact factor: 5.422

6.  FOXO1 deletion reduces dendritic cell function and enhances susceptibility to periodontitis.

Authors:  Wenmei Xiao; Guangyu Dong; Sandra Pacios; Maher Alnammary; Laura A Barger; Yu Wang; Yingying Wu; Dana T Graves
Journal:  Am J Pathol       Date:  2015-04       Impact factor: 4.307

7.  Loss of Rictor in tubular cells exaggerates lipopolysaccharide induced renal inflammation and acute kidney injury via Yap/Taz-NF-κB axis.

Authors:  Yuan Gui; Qing Hou; Qingmiao Lu; Chunsun Dai; Jianzhong Li
Journal:  Cell Death Discov       Date:  2020-05-29

8.  FoxO1 is a critical regulator of M2-like macrophage activation in allergic asthma.

Authors:  Sangwoon Chung; Ji Y Kim; Min-Ae Song; Gye Y Park; Yong G Lee; Manjula Karpurapu; Joshua A Englert; Megan N Ballinger; Navjot Pabla; Hae Y Chung; John W Christman
Journal:  Allergy       Date:  2018-11-05       Impact factor: 13.146

9.  Inhibition of GSK3 abolishes bacterial-induced periodontal bone loss in mice.

Authors:  Karina Adamowicz; Huizhi Wang; Ravi Jotwani; Iris Zeller; Jan Potempa; David A Scott
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

10.  Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction.

Authors:  Brian R Rosborough; Dàlia Raïch-Regué; Benjamin M Matta; Keunwook Lee; Boyi Gan; Ronald A DePinho; Holger Hackstein; Mark Boothby; Hēth R Turnquist; Angus W Thomson
Journal:  Blood       Date:  2013-02-26       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.